Open App
you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Oct 04, 15:45
4412.05 -8.10 (-0.18%)
Volume
No Data Available
10,776
  • Prev. Close

    4420.15

  • Open Price

    4440.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 04, 15:46
4413.95 -5.70 (-0.13%)
Volume
AVERAGE VOLUME
5-Day
668,093
10-Day
553,241
30-Day
386,619
308,641
  • Prev. Close

    4419.65

  • Open Price

    4446.00

  • Bid Price (Qty.)

    4413.95 (76)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2021 2020 2019 2018 2017
Quarterly Results of Dr Reddys Laboratories (in Rs. Cr.) Jun '22 Mar '22 Dec '21 Sep '21 Jun '21  
Net Sales/Income from operations 3,615.60 3,631.90 3,479.60 3,823.40 3,433.50  
Other Operating Income 15.00 36.80 -- -- --  
Total Income From Operations 3,630.60 3,668.70 3,479.60 3,823.40 3,433.50  
EXPENDITURE  
Consumption of Raw Materials 804.70 1,014.90 507.80 673.20 870.70  
Purchase of Traded Goods 483.60 335.40 753.80 656.20 623.50  
Increase/Decrease in Stocks 17.20 -55.70 -56.60 25.20 -302.50  
Power & Fuel -- -- -- -- --  
Employees Cost 649.00 608.90 604.00 635.20 586.50  
depreciat 221.50 205.20 205.40 206.60 197.10  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses 1,096.60 1,085.50 -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- 9.80 -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses -- -- 1,056.60 1,085.30 1,093.40  
P/L Before Other Inc. , Int., Excpt. Items & Tax 358.00 464.70 408.60 541.70 364.80  
Other Income 403.40 114.70 63.00 118.10 186.20  
P/L Before Int., Excpt. Items & Tax 761.40 579.40 471.60 659.80 551.00  
Interest 9.80 12.70 7.70 11.10 6.50  
P/L Before Exceptional Items & Tax 751.60 566.70 463.90 648.70 544.50  
Exceptional Items -- -- -- -- --  
P/L Before Tax 751.60 566.70 463.90 648.70 544.50  
Tax 252.10 147.00 122.80 199.70 131.10  
P/L After Tax from Ordinary Activities 499.50 419.70 341.10 449.00 413.40  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 499.50 419.70 341.10 449.00 413.40  
Equity Share Capital 83.20 83.20 83.20 83.20 83.20  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 30.10 25.29 20.55 27.07 24.94  
Diluted EPS 30.03 25.24 20.51 27.00 24.87  
EPS After Extra Ordinary  
Basic EPS. 30.10 25.29 20.55 27.07 24.94  
Diluted EPS. 30.03 25.24 20.51 27.00 24.87  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs